Hepatocellular carcinoma with macrovascular invasion:need a personalized medicine for this complicated event  

作　　者：Hyeonseung Hwang Ju Hyun Shim Jin Hyoung Kim 

机构地区：[1]Department of Radiology and Research Institute of Radiology,Asan Medical Center,University of Ulsan College of Medicine,Seoul,Korea [2]Department of Gastroenterology,Asan Medical Center,University of Ulsan College of Medicine,Seoul,Korea

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第1期188-190,共3页肝胆外科与营养（英文）

摘　　要：Hepatocellular carcinoma(HCC)is a hypervascular tumor and has a tendency to invade portal vein(PV)or hepatic vein(HV).HCC with macrovascular invasion(MVI)is associated with poor prognosis(1).HCC invasion of PV can lead to rapid intrahepatic tumor spread.In addition,portal vein tumor thrombus(PVTT)may result in deterioration of hepatic function,as well as increased risk of portal hypertensive complications(2).HCC invasion of HV is associated with increased risk of systemic metastasis.Furthermore.

关 键 词：INVASION HEPATIC HYPERTENSIVE 

分 类 号：R735.7[医药卫生—肿瘤]